Preparing Patients and Care Teams for Expected vs High-Risk Toxicities

This program was supported by Jazz Pharmaceuticals; content independence maintained by Pharmacy Times.

In this segment, Matthew Arango, PharmD, walks through the essential counseling points pharmacists emphasize when patients begin HER2-directed therapy, helping them recognize what side effects are expected versus symptoms that require urgent attention. He also outlines how pharmacists prepare clinical teams for potential infusion reactions. In addition, Arango explains the clinical cues that distinguish mild, moderate, and severe diarrhea with these agents and highlights preventative approaches, including strategies used proactively in recent trials.